Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 1
1992 1
1993 1
1994 1
1996 1
2003 1
2005 2
2007 1
2010 1
2011 1
2015 1
2019 1
2020 2
2021 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma.
Choueiri TK, Powles T, Albiges L, Burotto M, Szczylik C, Zurawski B, Yanez Ruiz E, Maruzzo M, Suarez Zaizar A, Fein LE, Schutz FA, Heng DYC, Wang F, Mataveli F, Chang YL, van Kooten Losio M, Suarez C, Motzer RJ; COSMIC-313 Investigators. Choueiri TK, et al. N Engl J Med. 2023 May 11;388(19):1767-1778. doi: 10.1056/NEJMoa2212851. N Engl J Med. 2023. PMID: 37163623 Free PMC article. Clinical Trial.
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Choueiri TK, Powles T, Burotto M, Escudier B, Bourlon MT, Zurawski B, Oyervides Juárez VM, Hsieh JJ, Basso U, Shah AY, Suárez C, Hamzaj A, Goh JC, Barrios C, Richardet M, Porta C, Kowalyszyn R, Feregrino JP, Żołnierek J, Pook D, Kessler ER, Tomita Y, Mizuno R, Bedke J, Zhang J, Maurer MA, Simsek B, Ejzykowicz F, Schwab GM, Apolo AB, Motzer RJ; CheckMate 9ER Investigators. Choueiri TK, et al. N Engl J Med. 2021 Mar 4;384(9):829-841. doi: 10.1056/NEJMoa2026982. N Engl J Med. 2021. PMID: 33657295 Free PMC article. Clinical Trial.
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.
Choueiri TK, Escudier B, Powles T, Mainwaring PN, Rini BI, Donskov F, Hammers H, Hutson TE, Lee JL, Peltola K, Roth BJ, Bjarnason GA, Géczi L, Keam B, Maroto P, Heng DY, Schmidinger M, Kantoff PW, Borgman-Hagey A, Hessel C, Scheffold C, Schwab GM, Tannir NM, Motzer RJ; METEOR Investigators. Choueiri TK, et al. N Engl J Med. 2015 Nov 5;373(19):1814-23. doi: 10.1056/NEJMoa1510016. Epub 2015 Sep 25. N Engl J Med. 2015. PMID: 26406150 Free PMC article. Clinical Trial.
Surfactant: current and potential therapeutic application in infants and adults.
Lewis J, Veldhuizen RA. Lewis J, et al. J Aerosol Med. 1996 Spring;9(1):143-54. doi: 10.1089/jam.1996.9.143. J Aerosol Med. 1996. PMID: 10160204 Review.
Although surfactant supplementation is now a routine therapy for babies born with neonatal RDS, this treatment modality for adults does not appear to result in a predictable improvement in lung function as is noted in neonates. This article will review the basic abnormalities …
Although surfactant supplementation is now a routine therapy for babies born with neonatal RDS, this treatment modality for adults does not …
Lipoprotein (a) in pregnancy: a critical review of the literature.
Manten GT, Voorbij HA, Hameeteman TM, Visser GH, Franx A. Manten GT, et al. Eur J Obstet Gynecol Reprod Biol. 2005 Sep 1;122(1):13-21. doi: 10.1016/j.ejogrb.2005.03.013. Eur J Obstet Gynecol Reprod Biol. 2005. PMID: 16154035 Review.
Sex-based analysis of treatment responses in animal models of sepsis: a preclinical systematic review protocol.
Zhang M, Fergusson DA, Sharma R, Khoo C, Mendelson AA, McDonald B, Macala KF, Sharma N, Gill SE, Fiest KM, Lehmann C, Shorr R, Jahandideh F, Bourque SL, Liaw PC, Fox-Robichaud A, Lalu MM; Canadian Critical Care Translational Biology Group, the Sepsis Canada National Preclinical Sepsis Platform. Zhang M, et al. Syst Rev. 2023 Mar 21;12(1):50. doi: 10.1186/s13643-023-02189-2. Syst Rev. 2023. PMID: 36945012 Free PMC article.
National Preclinical Sepsis Platform: developing a framework for accelerating innovation in Canadian sepsis research.
Mendelson AA, Lansdell C, Fox-Robichaud AE, Liaw P, Arora J, Cailhier JF, Cepinskas G, Charbonney E, Dos Santos C, Dwivedi D, Ellis CG, Fergusson D, Fiest K, Gill SE, Hendrick K, Hunniford VT, Kowalewska PM, Krewulak K, Lehmann C, Macala K, Marshall JC, Mawdsley L, McDonald B, McDonald E, Medeiros SK, Muniz VS, Osuchowski M, Presseau J, Sharma N, Sohrabipour S, Sunohara-Neilson J, Vázquez-Grande G, Veldhuizen RAW, Welsh D, Winston BW, Zarychanski R, Zhang H, Zhou J, Lalu MM; Sepsis Canada’s National Preclinical Sepsis Platform. Mendelson AA, et al. Intensive Care Med Exp. 2021 Mar 19;9(1):14. doi: 10.1186/s40635-020-00366-4. Intensive Care Med Exp. 2021. PMID: 33738642 Free PMC article.
Off to a good start after a cancer diagnosis: implementation of a time out consultation in primary care before cancer treatment decision.
Noteboom EA, de Wit NJ, van Asseldonk IJEM, Janssen MCAM, Lam-Wong WY, Linssen RHPJ, Pepels MJAE, Schrama NAWP, Trompper MEH, Veldhuizen LM, Wijtvliet AP, Zeldenrust EGF, Hendrikx AM, van de Boomen WA, Elbersen DM, Jacobs EMG, van der Wall E, Helsper CW. Noteboom EA, et al. J Cancer Surviv. 2020 Feb;14(1):9-13. doi: 10.1007/s11764-019-00814-5. Epub 2019 Nov 16. J Cancer Surviv. 2020. PMID: 31734854 Free PMC article.
21 results